Vanda Pharmaceuticals (VNDA) Operating Margin (2016 - 2025)
Historic Operating Margin for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q3 2025 value amounting to 55.61%.
- Vanda Pharmaceuticals' Operating Margin fell 325200.0% to 55.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 57.1%, marking a year-over-year decrease of 374600.0%. This contributed to the annual value of 20.46% for FY2024, which is 132100.0% down from last year.
- Vanda Pharmaceuticals' Operating Margin amounted to 55.61% in Q3 2025, which was down 325200.0% from 73.21% recorded in Q2 2025.
- In the past 5 years, Vanda Pharmaceuticals' Operating Margin ranged from a high of 18.22% in Q2 2021 and a low of 81.99% during Q1 2025
- In the last 5 years, Vanda Pharmaceuticals' Operating Margin had a median value of 12.74% in 2022 and averaged 13.43%.
- As far as peak fluctuations go, Vanda Pharmaceuticals' Operating Margin surged by 167200bps in 2021, and later crashed by -625300bps in 2025.
- Over the past 5 years, Vanda Pharmaceuticals' Operating Margin (Quarter) stood at 12.7% in 2021, then decreased by -19bps to 10.28% in 2022, then tumbled by -252bps to 15.67% in 2023, then fell by -23bps to 19.33% in 2024, then tumbled by -188bps to 55.61% in 2025.
- Its Operating Margin stands at 55.61% for Q3 2025, versus 73.21% for Q2 2025 and 81.99% for Q1 2025.